Literature DB >> 469673

The spectrum of ABO hemolytic disease of the newborn infant.

L Desjardins, M A Blajchman, C Chintu, M Gent, A Zipursky.   

Abstract

A series of 1,704 infants of blood group O mothers have been studied to determine the relation between the degree of red cell sensitization and the cord hemoglobin and bilirubin concentrations. The infants with blood group A or B had significantly higher cord bilirubin and lower cord hemoglobin concentrations than the group O babies. Those infants whose red cells had the greatest evidence of sensitization had the highest bilirubin and lowest hemoglobin levels. The infants in whom no antibody was demonstrable on the red cells or in the red cell eluate also had significantly higher cord bilirubin and lower cord hemoglobin levels than the ABO compatible group; it is suggested that these infants had sufficient erythrocyte sensitization to produce mild hemolysis. ABO incompatibility represents a spectrum of hemolytic disease extending from those in which there is little laboratory evidence of erythrocyte sensitization, but evidence of hemolysis, to severe hemolytic disease in which erythrocyte sensitization is usually easily demonstrable.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 469673     DOI: 10.1016/s0022-3476(79)80533-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  ABO Hemolytic Disease of Fetus and Newborn; Still a Diagnostic Dilemma: A Case Report.

Authors:  Vijay Kumawat; Keerti Kulkarni; Manu Goyal; Venkat Lokadas
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-23       Impact factor: 0.900

2.  Unusually severe ABO hemolytic disease of newborn.

Authors:  J Goraya; S Basu; P Sodhi; S Mehta
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

3.  Early diagnosis of ABO haemolytic disease of the newborn.

Authors:  R S Procianoy; C B Giacomini; D M Farina; G A Mollin; M I Winckler; M B Silveira; L Campos; J P Marques-Pereira
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

4.  International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.

Authors:  Lani Lieberman; Enrico Lopriore; Jillian M Baker; Rachel S Bercovitz; Robert D Christensen; Gemma Crighton; Meghan Delaney; Ruchika Goel; Jeanne E Hendrickson; Amy Keir; Denise Landry; Ursula La Rocca; Brigitte Lemyre; Rolf F Maier; Eduardo Muniz-Diaz; Susan Nahirniak; Helen V New; Katerina Pavenski; Maria Cristina Pessoa Dos Santos; Glenn Ramsey; Nadine Shehata
Journal:  Br J Haematol       Date:  2022-04-12       Impact factor: 8.615

5.  Early indicators of neonatal-onset hereditary thrombotic thrombocytopenia purpura.

Authors:  Jing Liu; Yuelun Zhang; Zhuo Li; Zhenghong Li; Lejia Zhang; Shan Jian; Changyan Wang; Yuqing Song; Zichao Lv; Xiaoyan Tang; Lijuan Gou; Juan Xiao
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.